nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-56FAEC56·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.2 Clinical medicine·Subfield: Molecular Biology·Basis: Full text·Type: Cross-sectional study

Distinct maternal metabolites are associated with obesity and glucose-insulin axis in the first trimester of pregnancy.

Bandres-Meriz et al.Bandres-Meriz, Kunz, Havelund et al.·2023·International journal of obesity (2005)·10.1038/s41366-023-01295-4 ↗

Primary claim

palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

Supported · cross-sectional associations persist after full-feature FDR correction, without independent replication
In brief

Early-pregnancy metabolomics identifies two C-peptide-associated candidates, but cross-sectional evidence cannot establish the proposed causal pathway.

ReliabilityConcerns4 of 4 checks completeRead the 2 entries ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND/OBJECTIVES: Obesity in pregnancy associates with changes in the glucose-insulin axis. We hypothesized that these changes affect the maternal metabolome already in the first trimester of human pregnancy and, thus, aimed to identify these metabolites.

PATIENTS/METHODS: We performed untargeted metabolomics (HPLC-MS/MS) on maternal serum (n = 181, gestational weeks 4+0-11+6). For further analysis, we included only non-smoking women as assessed by serum cotinine levels (ELISA) (n = 111). In addition to body mass index (BMI) and leptin as measures of obesity and adiposity, we metabolically phenotyped women by their fasting glucose, C-peptide and insulin sensitivity (ISHOMA index). To identify metabolites (outcome) associated with BMI, leptin, glucose, C-peptide and/or ISHOMA (exposures), we used a combination of univariable and multivariable regression analyses with multiple confounders and machine learning methods (Partial Least Squares Discriminant Analysis, Random Forest and Support Vector Machine). Additional statistical tests confirmed robustness of results. Furthermore, we performed network analyses (MoDentify package) to identify sets of correlating metabolites that are coordinately regulated by the exposures.

RESULTS: We detected 2449 serum features of which 277 were annotated. After stringent analysis, 15 metabolites associated with at least one exposure (BMI, leptin, glucose, C-peptide, ISHOMA). Among these, palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses (95% CI: 0.10-0.34; effect size: 21%; p < 0.001; 95% CI: 0.04-0.10; effect size: 7%; p < 0.001). In network analysis, most features correlating with palmitoleoyl ethanolamide and N-acetyl-L-alanine and associated with C-peptide, were amino acids or dipeptides (n = 9, 35%), followed by lipids (n = 7, 27%).

CONCLUSIONS: We conclude that the metabolome of pregnant women with overweight/obesity is already altered early in pregnancy because of associated changes of C-peptide. Changes of palmitoleoyl ethanolamide concentration in pregnant women with obesity-associated hyperinsulinemia may reflect dysfunctional endocannabinoid-like signalling.

Key Claims

Primary finding · Supported

palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

cross-sectional associations persist after full-feature FDR correction, without independent replication

Abstract, Results
Quote verified
Secondary · Tentative

We conclude that the metabolome of pregnant women with overweight/obesity is already altered early in pregnancy because of associated changes of C-peptide.

contemporaneous observational measurements and incomplete confounding control cannot establish the proposed causal pathway

Abstract, Conclusions
Quote verified
Secondary · Tentative

After stringent analysis, 15 metabolites associated with at least one exposure (BMI, leptin, glucose, C-peptide, ISHOMA)

same-sample selection and unadjusted multivariable testing leave most candidates without full-feature multiplicity-adjusted support

Abstract, Results; Table 2
Quote verified
Secondary · Supported

Leptin (p < 0.001) and C-peptide (p = 0.009) concentrations were significantly increased, and insulin sensitivity decreased (p = 0.002) in the group with overweight-obesity compared to the underweight-normal weight group.

reported group comparisons support these differences within a selected cross-sectional cohort

Results, Study participants
Quote verified
Secondary · Tentative

Two metabolites: tryptamine and 2,3,4,9-tetrahydro-1H-carboline-3-carboxylic acid were inversely associated with ISHOMA [in the overweight-obesity sub-cohort]. The association remained significant in multivariable analysis after adjusting for confounders (Table 5).

small subgroups of nine and 23 participants leave adjusted exploratory associations vulnerable to small-sample uncertainty

Results, The metabolome in healthy or unhealthy obesity; Table 5
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Two candidates survive broader multiplicity control

Palmitoleoyl ethanolamide and N-acetyl-L-alanine remain associated with C-peptide in the all-feature analysis as well as the adjusted models. This supports their prioritisation for subsequent research, not independent replication.

↳ Results, Robustness of the results; Tables 2–3

#methodological rigour

Fasting sampling with biochemical smoking verification

Blood was collected after overnight fasting, and inclusion required both self-reported non-smoking and undetectable serum cotinine. These procedures reduce variation associated with recent intake and smoking.

↳ Methods, Sample collection and analyses

#positioning

Findings situated within pregnancy metabolism literature

The paper distinguishes first-trimester questions from later-pregnancy evidence and explains how untargeted profiling extends earlier targeted analyses of the same cohort.

↳ Introduction; Discussion

Limitations

#methodological rigour

Causal interpretation lacks timing and confounding control

C-peptide and metabolites were measured contemporaneously, so the asserted causal direction is not identified. Adjustment for gestational age, maternal age and processing time does not resolve plausible confounding by adiposity or diet.

↳ Methods, Sample collection and analyses; Multivariable regression analysis; Abstract Conclusions

#reporting

Stringent candidate framing exceeds exploratory evidence

The 15 candidates were selected and tested in the same cohort without multiplicity adjustment of the selected multivariable tests, while only two retained the highlighted exposure associations in the full-feature analysis. Generalisation is also restricted by unexamined selection from a termination-clinic, non-smoking population containing only six women with obesity.

↳ Methods, Participants and Multivariable regression analysis; Abstract Results; Tables 2–3

#methodological rigour

Reported effect size changes across locations

The abstract gives N-acetyl-L-alanine an effect size of 7%, whereas Table 2 reports R² = 0.18, equivalent to 18%. That changes the stated magnitude by 11 percentage points, although the positive association and reported p < 0.001 remain.

↳ Abstract Results; Table 2, N-acetyl-L-alanine row

Does this match your read? Add your assessment ↓

Nabu Commentary

The study's clearest contribution is the persistence of two C-peptide associations across adjusted models and the full-feature FDR analysis in Tables 2–3. Fasting sampling and cotinine verification strengthen measurement, but contemporaneous collection and an incomplete confounding strategy cannot establish that C-peptide causes metabolomic changes. The description of all 15 candidates as stringently identified exceeds the support from same-cohort analyses with unadjusted selected-model tests. The termination-clinic population and limited obesity representation further restrict scope, while the abstract's effect-size error requires correction independently of these methodological limitations.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.6±0.2

Contribution
3.3

The study extends early-pregnancy metabolic profiling by identifying two C-peptide-associated candidates across adjusted and full-feature analyses. Its contribution remains exploratory and incremental because the cohort is reused and independent replication is absent.

Introduction; Results, Tables 2–3
Methodological Rigour
2.0

Fasting collection, biochemical smoking exclusion and full-feature FDR analysis support exploratory associations, but contemporaneous measurement and incomplete confounding control substantially undermine the causal conclusion. The score reflects these methodological merits and defects, while the separate reliability flag identifies the abstract's 7% effect size versus Table 2's 18%.

Methods, Sample collection and analyses; Multivariable regression analysis; Abstract Conclusions; Tables 2–3
Reporting
2.8

The workflow and tables make the analysis sequence followable, but describing all 15 candidates as stringently established obscures their differing evidentiary status. Numerical reporting errors further complicate interpretation.

Figure 1; Abstract Results; Results, Robustness of the results; Tables 2–3
Positioning
3.2

The Introduction and Discussion relate the findings to later-pregnancy metabolomics, prior cohort analyses and relevant metabolic mechanisms. The limitations are explicitly listed, but their implications for robustness and interpretation are incompletely developed.

Introduction; Discussion, literature comparisons and limitations paragraphs

Reliability

Concerns4 of 4 checks


Results checkConcern
  • palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses (95% CI: 0.10-0.34; effect size: 21%; p < 0.001; 95% CI: 0.04-0.10; effect size: 7%; p < 0.001): "95% CI: 0.04-0.10; effect size: 7%; p < 0.001" (Abstract, Results) vs "N-acetyl-L-alanine0.070.04 to 0.100.18<0.001" (Table 2, N-acetyl-L-alanine row). Table 2 labels effect size as R², so 0.18 corresponds to 18%, which is 11 percentage points above the abstract's 7%. → Changes the size materially
Reporting and transparencyNoted

Ethics approval is declared, including one approval before recruitment and another dated after the reported collection window. The text does not establish whether the later approval was an amendment.

Ethics approval: declared

Reference IntegrityClean

54 of 54 checkable references verified

55 references in manuscript 1 are books, websites or datasets — counted, but not index-checkable

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Metabolic and endocrine · Endocrine, metabolic, blood, and immune disorders
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesCatch-all cause
CitationsFWCI 0.8
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on cross-sectional statistical associations in a single 111-woman observational cohort, with no intervention, mechanism experiment, or validated tool shown working.

From the paper
“this time period may offer an intervention window for medical and dietary counselling to reduce the risk of adverse pregnancy outcomes”

The paper names a practice use, early medical and dietary counselling to prevent GDM and adverse pregnancy outcomes, but names no specific actor, organisation or decision setting.

Pathway

Obstetric and prenatal care teams could use early-pregnancy metabolite changes to time dietary and medical counselling aimed at preventing gestational diabetes and adverse pregnancy outcomes.

Barrier

These cross-sectional associations come from a single small cohort without pregnancy-outcome follow-up, so POEA and N-acetyl-L-alanine require validation before clinical use.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats
  2. The endogenous exposome of the pregnant mother: Placental extracellular vesicles and their effect on the maternal system

    Nadja Kupper, Berthold Huppertz · 2021 · Basic medicine

    Primary claim

    in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.

    Tentative
    Evidence Score
    3.2±0.1
    Reliability
    Caveats
  3. Tig1 regulates proximo-distal identity during salamander limb regeneration

    Oliveira, Knapp, Elewa, et al. · 2022 · Biological sciences

    Primary claim

    Tig1 reprogrammes distal cells to a proximal identity, upregulating Prod1 and inhibiting Hoxa13 and distal transcriptional networks

    Tentative
    Evidence Score
    3.8±0.1
    Reliability
    Caveats

How the rubric works →